Observational Study of Effectiveness and Tolerability of Gliclazide MR 60mg in Diabetic Patients Fasting During RAMADAN
NCT04132934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200
Last updated 2020-06-05
Summary
The purpose of this observational study is to assess effectiveness and tolerability of gliclazide MR 60mg during RAMADAN in a real world setting in 9 countries from Asia Pacific and Middle East/North Africa
Conditions
Sponsors & Collaborators
-
Servier Affaires Médicales
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-11
- Primary Completion
- 2019-10-04
- Completion
- 2019-10-04
Countries
- France
Study Locations
More Related Trials
-
Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs
NCT01203111 ·Status: COMPLETED ·Phase: PHASE4
-
Trial for People With Established Type 2 Diabetes During Ramadan
NCT02292290 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes
NCT00191464 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan
NCT02648217 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Glargine in Type 2 Diabetic Patients
NCT00347100 ·Status: COMPLETED ·Phase: PHASE4
-
Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan
NCT01354925 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
NCT01175824 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin
NCT00036504 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Patients With Type 2 Diabetes Mellitus
NCT01435616 ·Status: COMPLETED ·Phase: PHASE3
-
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
NCT01713530 ·Status: COMPLETED ·Phase: PHASE3
-
Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients: Comparison Between DAR Recommendations and the Carbohydrate Fasting Test & Metabolic and Inflammatory Consequences
NCT06826547 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients
NCT02987751 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine
NCT00976391 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus
NCT00290927 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
NCT01794143 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
NCT04153981 ·Status: COMPLETED ·Phase: PHASE4
-
Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast
NCT00664534 ·Status: COMPLETED ·Phase: PHASE4
-
Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan
NCT03349840 ·Status: TERMINATED ·Phase: PHASE4
-
To Demonstrate the Effect of Food on the Bioavailability of Glipizide
NCT00947024 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Lispro Formulations in Healthy Participants
NCT02293551 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
NCT06982846 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Glulisine + Lantus in Type I Patients
NCT00546702 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes
NCT00191178 ·Status: COMPLETED ·Phase: PHASE4
-
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
NCT01136746 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
NCT00343980 ·Status: TERMINATED ·Phase: PHASE3